-- Braden Michael Leonard, 10% Owner, on April 27, 2026, sold 300,000 shares in Aclaris Therapeutics (ACRS) for $1,359,000. Following the Form 4 filing with the SEC, Leonard has control over a total of 13,950,000 common shares of the company, with 13,950,000 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1557746/000137360426000034/xslF345X05/form4.xml